AzTrials
AzTrials

Age-related Hearing ImpairmentK-HEARSNCT06803394

Hearing Health Equity Through Accessible Research and Solutions for Korean Americans

A study testing K-HEARS Intervention and K-HEARS Sound Amplifier Intervention in people with Age-related Hearing Impairment and Personal Communication, run by Johns Hopkins University at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The objective of this study is to test the effect of a community-delivered, affordable, and accessible hearing care intervention on improving communication function and health-related quality of life among older Korean Americans (KA) and the older Korean American's care partners that integrates a low-cost… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
K-HEARS Intervention and K-HEARS Sound Amplifier Intervention
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
800 participants
Where
1 siteUnited States
Study dates
9 Feb 2025to 30 Sep 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

PARTICIPANT CRITERIA Participant inclusion criteria

  • Self-identified as first-generation KA in the target region
  • Age 60 years or older
  • Has a communication partner who lives in the same household or has at least weekly interactions
  • Screening audiometry Pure-tone audiometry (PTA)1,2,4 kilohertz (kHz) >25 decibel (dB) hearing loss (HL) in better ear
  • Hearing handicap as measured by HHIE-S score >=8 Participant exclusion criteria
  • Current use of hearing aid
  • Medical contraindications to use amplification device (e.g., draining ear)
  • Plan to move from the area within 6 months
  • Active treatment for a terminal illness or in hospice

COMMUNICATION PARTNER CRITERIA Communication Partner inclusion criteria

  • Age 18 years or older
  • Able to read and speak Korean
  • Lives with the older adult or has at least weekly interactions Communication Partner exclusion criteria
  • Plan to move from the area within 6 months
  • Active treatment for a terminal illness or in hospice

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • Johns Hopkins School of Nursing

    Baltimore, Maryland, 21205

Other trials in United States

About this study

The objective of this study is to test the effect of a community-delivered, affordable, and accessible hearing care intervention on improving communication function and health-related quality of life among older Korean Americans (KA) and the older Korean American's care partners that integrates a low-cost over-the-counter amplification device and hearing rehabilitation in comparison to a 6-month delayed treatment group through a cluster randomized controlled study.

Being tested
K-HEARS Intervention, K-HEARS Sound Amplifier Intervention
Medical subject headings
Communication, Hearing Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • K-HEARS InterventionBehavioural

    Tailored aural rehabilitation for participant and care partner

  • K-HEARS Sound Amplifier InterventionDevice

    Tailored fitting and programming of a personal sound amplifier. This will be accompanied by a component of aural rehabilitation.

Study groups in NCT06803394
Study groupRoleWhat they receive
Immediate Treatment SiteExperimentalStudy site assigned to immediate treatment of K-HEARS intervention
Receives: Behavioral: K-HEARS Intervention; Device: K-HEARS Sound Amplifier Intervention
Delayed Treatment SitePlacebo comparatorStudy site assigned to 6-month delayed treatment of K-HEARS intervention
Receives: Behavioral: K-HEARS Intervention; Device: K-HEARS Sound Amplifier Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hearing Handicap Inventory for the Elderly (HHIE-S) score

    Score range 0-40. 0-8 suggests no hearing handicap 10-24 suggests mild-moderate hearing handicap 26-40 suggests significant hearing handicap.

    Measured: Baseline, 6 months post-intervention (Immediate Group). 6 months post-baseline (Delayed Group)

Secondary outcomes (2)
  1. Third Party Disability as assessed by the Significant Other Scale for Hearing Disability (SOS-HEAR)

    Third-party disability will be measured in communication partners using the Significant Other Scale for Hearing Disability (SOS-HEAR). Score range 0-104, with higher score more disability.

    Measured: Baseline, 6 months post-intervention (Immediate Group). 6 months post-baseline (Delayed Group)

  2. Relationship Quality as assessed by the Mutuality Scale

    Relationship quality will be measured using the Mutuality Scale among participants and communication partners. Score range 0-60, with higher score better relationship quality.

    Measured: Baseline, 6 months post-intervention (Immediate Group). 6 months post-baseline (Delayed Group)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jan 2025
  2. Study start9 Feb 2025
  3. Primary completion1 Feb 2028 (estimated)
  4. Study completion30 Sep 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
800 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06803394
Sponsor's protocol ID
IRB00406742
Other IDs
R01DC019686
Acronym
K-HEARS
Status last verified
Mar 2026
First submitted
27 Jan 2025
Last updated
12 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing K-HEARS Intervention and K-HEARS Sound Amplifier Intervention in people with Age-related Hearing Impairment and Personal Communication, run by Johns Hopkins University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 12 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hearing Handicap Inventory for the Elderly (HHIE-S) score (time frame: Baseline, 6 months post-intervention (Immediate Group). 6 months post-baseline (Delayed Group)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in